Mallinckrodt plc

(MNK) Trade

By |

Profile

Mallinckrodt is a specialty pharmaceutical company that was spun off from Covidien and historically focused on pain therapeutics. After recently moving its generics business into discontinued operations, Mallinckrodt now focuses entirely on branded drugs following the sale of its nuclear imaging business in 2016. Mallinckrodt's products now span a number of therapeutic areas, but a significant portion focus on hospital and clinical customers.

Contact Information

Website: www.mallinckrodt.com
Email: investor.relations@mnk.com
Main Phone: +44 1784636700
Address: 3 Lotus Park, The Causeway
State: Surrey
City / Town: Staines-Upon-Thames
Country: GBR
Postal Code: TW18 3AG

Issuer Information

Exchange: NYE
CEO: Mark C. Trudeau
Employees: 3900
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 18.35 $ -0.85 (-4.43%)
Last Price 18.35 Change $ -0.85 Change % -4.43 Tick N/A
Bid 18.34 Bid Size 200.00 Ask 18.36 Ask Size 300.00
Open 19.05 High 19.53 Low 18.26 Prev Close 19.20
Last Trade Volume 1.5 mi 52 Wk Hi 36.65 52 Wk Low 11.65
Market Cap 1.5 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 83,313,240.00 EPS (TTM) 17.85 PE Ratio 1.10 Exchange NYSE
  Last 3 Mo Last 12 Mo
Number of Insider Trades 19 67
Number of Buys 15 24
Number of Sells 4 43
Net Activity -7229 -27407
Last 10 Buys Shares
Mark C. Trudeau 1,000
Last 10 Sell Shares
Flynn E James 1,000
Flynn E James 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 42 42 42 42
Low Target Price Estimate 12 12 12 12
Mean Target Price Estimate 19.56 19.56 19.56 19.56
Standard Deviation 8.78 8.78 8.78 8.78
Date of Most Recent Estimate 06/04/18 05/22/18 05/22/18 06/04/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 5 5 5 6
Moderate Buy 1 1 1 1
Hold 11 10 10 8
Moderate Sell 1 1 0 0
Strong Sell 1 1 1 1
Mean Rec. 2.58 2.56 2.47 2.31